This federal contract award is for the delivery of TWINRIX VACCINE SYRINGEML to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $97,641.06. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the period of performance extends through December 11, 2024.
The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/16/25, 12:54 AM